CryoLife Enhances Management Team with Promotions

New Vice Presidents Provide Added Focus to Key Growth Drivers

06-Jan-2012 - USA

CryoLife, Inc. announced that it has promoted David C. Gale, Ph.D., to the position of Vice President, Research and Development; and David P. Lang to the newly created position of Vice President, Market Development Surgical Adhesives and Starch Medical Relations. Dr. Gale will report to Steven G. Anderson, President and Chief Executive Officer and Mr. Lang will report to Gerald B. Seery, Senior Vice President, Sales and Marketing.

David C. Gale, Ph.D. joined CryoLife in 2009 as Senior Director of Research and Development. Prior to joining CryoLife, he was Vice President, Research and Development of Sinexus Inc., a manufacturer of drug-eluting (or releasing) stents located in Palo Alto, California. He previously worked in research and development of bioabsorbable polymers and stents at Abbott Laboratories and Birmingham Polymers. David Gale has a B.S. in Chemistry and an M.S. in Instrumentation and Analysis from the University of Manchester in England. He also holds an M.S. in Chemical Engineering from Auburn University and a Ph.D. in Materials Science from the University of Alabama, Birmingham.

David P. Lang joined CryoLife in 2010, as Vice President of PerClot Market Development, CryoLife International in Munich, Germany. Prior to joining CryoLife International, David Lang was President and then consultant to Starch Medical, Inc. His senior management positions include three resident assignments in Paris, Munich, and Shanghai. He was a founder of the first Sino-American medical electronics joint venture in China in 1985. David Lang received a B.A. in Economics from Harvard University.

https://www.bionity.com/en/news/135840/cryolife-enhances-management-team-with-promotions.html